title: Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registry.
abstract: BACKGROUND
  Cardiovascular magnetic resonance (CMR) is increasingly used in daily clinical practice. However, little is known about its clinical utility such as image quality, safety and impact on patient management. In addition, there is limited information about the potential of CMR to acquire prognostic information.
  
  
  METHODS
  The European Cardiovascular Magnetic Resonance Registry (EuroCMR Registry) will consist of two parts: 1) Multicenter registry with consecutive enrolment of patients scanned in all participating European CMR centres using web based online case record forms. 2) Prospective clinical follow up of patients with suspected coronary artery disease (CAD) and hypertrophic cardiomyopathy (HCM) every 12 months after enrolment to assess prognostic data.
  
  
  CONCLUSIONS
  The EuroCMR Registry offers an opportunity to provide information about the clinical utility of routine CMR in a large number of cases and a diverse population. Furthermore it has the potential to gather information about the prognostic value of CMR in specific patient populations.
authors.affiliation: Department of Cardiology, Hahnemann University Hospital, Drexel University College of Medicine, Philadelphia, USA. anja.wagner@gmail.com
authors.forename: Anja
authors.initials: A
authors.lastname: Wagner
authors.forename: Oliver
authors.initials: O
authors.lastname: Bruder
authors.forename: Steffen
authors.initials: S
authors.lastname: Schneider
authors.forename: Detlev
authors.initials: D
authors.lastname: Nothnagel
authors.forename: Peter
authors.initials: P
authors.lastname: Buser
authors.forename: Guillem
authors.initials: G
authors.lastname: Pons-Lado
authors.forename: Thorsten
authors.initials: T
authors.lastname: Dill
authors.forename: Vinzenz
authors.initials: V
authors.lastname: Hombach
authors.forename: Massimo
authors.initials: M
authors.lastname: Lombardi
authors.forename: Albert C
authors.initials: AC
authors.lastname: van Rossum
authors.forename: Juerg
authors.initials: J
authors.lastname: Schwitter
authors.forename: Jochen
authors.initials: J
authors.lastname: Senges
authors.forename: Georg V
authors.initials: GV
authors.lastname: Sabin
authors.forename: Udo
authors.initials: U
authors.lastname: Sechtem
authors.forename: Heiko
authors.initials: H
authors.lastname: Mahrholdt
authors.forename: Eike
authors.initials: E
authors.lastname: Nagel
mesh_terms: D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis*; D003324:Coronary Artery Disease / Q000175:diagnosis*; D005060:Europe; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000009:adverse effects; D016347:Medical Records Systems, Computerized; D011237:Predictive Value of Tests; D011379:Prognosis; D011446:Prospective Studies; D012042:Registries; D012107:Research Design; D018570:Risk Assessment; D013997:Time Factors